FindTrial
Sign In

Ipilimumab Injection [Yervoy]

DRUG3 trials

Sponsors

Sheba Medical Center, Inge Marie Svane, Herlev and Gentofte Hospital

Conditions

Castrate Resistant Prostate CancerColorectal Neoplasms MalignantLiver MetastasesMalignant MelanomaMetastatic Castration-resistant Prostate CancerProstate Cancer MetastaticProstate Cancer Stage IV

Phase 1

Combined Immunotherapy and Radiosurgery for Metastatic Colorectal Cancer
CompletedNCT03507699
Sheba Medical CenterColorectal Neoplasms Malignant, Liver Metastases
Start: 2018-12-15End: 2022-05-25Updated: 2023-04-18

Phase 2

Melanoma Metastasized to the Brain and Steroids
RecruitingNCT03563729
Inge Marie SvaneMalignant Melanoma
Start: 2018-06-06End: 2028-06-06Target: 80Updated: 2023-07-13
Checkpoint Inhibitors and SBRT for MCRPC
CompletedNCT05655715
Herlev and Gentofte HospitalCastrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic +1
Start: 2019-11-25End: 2024-08-30Updated: 2024-10-16

Related Papers

CA209-8TY trial, a randomized phase 2 trial of nivolumab and ipilimumab with or without stereotactic body radiation therapy in metastatic castration-resistant prostate cancer.
Journal of Clinical Oncology2025-05-28
Combination treatment of intratumoral vidutolimod (CMP-001), radiosurgery, nivolumab, and ipilimumab for metastatic colorectal carcinoma.
Journal of Clinical Oncology2023-01-243 citations
Randomised phase II trial of stereotactic body radiotherapy in combination with<b>check</b>point inhibitors in metastatic castration-resistant<b>pro</b>state cancer (CheckPRO): a study protocol
BMJ Open2023-01-013 citations